Probe ADME and Test Hypotheses: a PATH beyond clearance in vitro–in vivo correlations in early drug discovery

Abstract

Introduction: In vitro cytochrome P450 (CYP450) metabolic profiling is pursued extensively to optimize drug properties. Still, the in vivo clearance of half of all new chemical entities (NCEs) remains poorly predicted by CYP450 metabolism, based on Novartis rat pharmacokinetic data. The conventional route to illuminating key drivers of in vivo clearance beyond hepatic metabolism is, frequently, the process of elimination, a time-consuming and sometimes resource-intensive practice. A more nimble and efficient diagnosis of drug clearance is imperative to support today's chemistry optimization.

Areas covered: This article reviews in vitro–in vivo clearance correlation (IVIVC) analysis of drugs and NCEs including in silico advances, in vitro opportunities for clearance characterization and guidance for proper interpretation of clearance data. Potential mechanisms for under- and overestimation of in vivo clearance obtained from in vitro approaches are reviewed. The article offers insight into a practical PATH (Probe ADME and Test Hypotheses) for discovery data analysis that can enrich IVIVC development and guide more efficient use of the ADME-PK toolbox.

Expert opinion: In vitro hepatic CYP450 stability measurements remain the most practical way to triage for high metabolic liabilities. Clearance is a complex process involving multiple mechanisms and many factors tend to be overlooked in routine correlation analyses. Equilibrium protein binding, intrinsic permeability and ionization may yield insight into distribution-limited clearance. In addition, hydrophobic character and transporter interaction can be valuable in diagnosing dominant clearance pathways. An integrated ADME approach to clearance interrogation is expected to help refine the in vitro–in silico strategies that guide medicinal chemistry.

Keywords::

• ADME
• CYP450
• human
• IVIVC
• mechanism of clearance
• metabolism
• pharmacokinetics
• rat

Acknowledgements

The authors specifically acknowledge P Nguyen, B Snodgrass and C Boiselle for generation of in vitro clearance data and for valuable discussion. The authors further recognize global Novartis MAP and ADME colleagues for contribution of high quality in vivo and in vitro mechanistic studies that enabled clearance interrogation. The efforts of Novartis Institutes of Biomedical Research IT department have supported much of this analysis and their contributions are greatly appreciated.

Notes

This box summarizes key points contained in the article.